Navigation Links
Uterine Fibroid Treatments Seem to Boost Quality of Life
Date:3/1/2011

TUESDAY, March 1 (HealthDay News) -- For women with uterine fibroids, three treatments have been found to relieve symptoms and result in major improvements in quality of life, according to a new study.

Up to 20 percent of women in their childbearing years develop uterine fibroids, which are benign pelvic tumors. Not all fibroids cause symptoms, but some patients experience heavy bleeding, pain and infertility, according to background information in the study, which is slated for publication in the May issue of the journal Radiology.

The researchers looked at three treatment options: hysterectomy; minimally invasive uterine artery embolization (UAE); and a noninvasive magnetic resonance-guided focused ultrasound (MRgFUS) procedure, which, unlike regular ultrasounds, which uses high doses of focused ultrasound waves guided by MR images to destroy tissue -- in this case, uterine fibroids.

The study included 197 women treated for symptomatic uterine fibroids at Brigham and Women's Hospital in Boston between 2004 and 2006. Of those patients, 62 underwent hysterectomy, 74 had the minimally invasive UAE, and 61 were treated with the MR-guided ultrasound procedure.

"Quality of life significantly increased following each of the fibroid treatment options. But patients rated the non- or minimally-invasive treatments -- UAE and MRgFUS -- more favorably," lead author Dr. Fiona M. Fennessy, an assistant professor of radiology at Harvard Medical School, said in a news release from the Radiological Society of North America.

A survey of the women found that those who underwent a hysterectomy said they would wait 21 weeks in order to avoid the procedure. By contrast, women in the other two groups said they would delay their procedures by only 14 weeks, the survey found.

"Our study not only provides measures to aid in future cost-utility analysis of uterine fibroid treatments, but it may be helpful to patient and physician decision-making with regard to treatment options," Fennessy said.

More information

The U.S. National Institute of Child Health and Human Development has more about uterine fibroids.

-- Robert Preidt

SOURCE: Radiological Society of North America, news release, March 1, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. A New Way to Zap Away Uterine Fibroids
2. Intrauterine devices reduce repeat abortions
3. New non-surgical treatment for uterine fibroids can improve quality of life
4. Intrauterine devices can be used to treat endometrial cancer
5. IUD Proposed to Treat Uterine Cancer
6. Race may influence uterine cancer recurrence, despite treatment
7. Drug May Shrink Fibroids, Preserve Fertility
8. Neuroimaging study may pave way for effective Alzheimers treatments
9. Charging less for more effective treatments could reduce health care costs while improving health
10. NIH grants to Childrens Hospital will advance novel stem cell treatments for blood disorders
11. Roseville Radiation Oncology Center (ROC) Redefines Efficiency With Elekta VMAT Radiotherapy Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Uterine Fibroid Treatments Seem to Boost Quality of Life
(Date:3/23/2017)... ... 23, 2017 , ... On 2 March 2017, the United ... Operations Command’s Patriot Award. The award was presented by the USSOCOM Commander, General ... for its significant and enduring support to the command. , Accepting the ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews ... http://www.fdanews.com/mdclineval                  , How will the new EU MDR language change the ...
(Date:3/23/2017)... Las Vegas, Nevada (PRWEB) , ... March 23, 2017 , ... ... March 25th from 10am - 2pm. All events will be located in the ... will be hosting a no-cost Child ID event. No appointment is necessary and each ...
(Date:3/23/2017)... ... March 23, 2017 , ... GeBBS Healthcare Solutions unveils the ... 21st annual Compliance Institute on March 26-28 in National Harbor, Maryland. ... chart types with a comprehensive set of features including built-in workflow, interactive audit ...
(Date:3/23/2017)... ... 2017 , ... News Advisory/Interview Opportunity , After six years of advocacy, testimony ... Europe for public health and the environment and is calling on the United States ... the overwhelming support of European citizens, the European Union (EU) will, beginning next year, ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... Research and Markets has announced the addition of the ... Insight 2022" drug pipelines to their offering. ... Global Immune ... gives comprehensive insight on clinical and non-clinical aspects involved in ... main streamline drugs in the immunotherapy treatment. Report helps to ...
(Date:3/22/2017)... Mar 22, 2017 Research and Markets has ... & Trends - Industry Forecast to 2025" report to their ... The ... of around 7.1% over the next decade to reach approximately $129.81 ... estimates and forecasts for all the given segments on global as ...
(Date:3/22/2017)... , March 22, 2017  Applied BioMath ( ... to drug research and development, today announced the ... QSP Day 2017 is a day full of ... systems pharmacology (QSP) community. The focus is to ... de-risking and accelerating drug research and development. ...
Breaking Medicine Technology: